Article preview from The RPM Report - July 2008 |
| Find out why July 23 was a challenging day for NexMed's lead product (Vitaros, a cream formulation of alprostadil for erectile dysfunction) and, by extension, for its platform technology (the NexACT permeation enhancer). |
Continue reading "NexMed Defends Vitaros: The Candid Approach " »
